Abstract: Aspects of the subject disclosure may include, for example, a non-transitory, machine-readable medium, comprising executable instructions that, when executed by a processing system including a processor, facilitate performance of operations including receiving a call; selecting a next carrier to handoff the call; generating a call data record (CDR) for the handoff to the next carrier; encrypting the CDR using a call encryption key, thereby creating an encrypted CDR; encrypting the encrypted CDR using a committee encryption key, thereby creating a double encrypted CDR; recording the double encrypted CDR to a blockchain; and sending the call encryption key to the next carrier. Other embodiments are disclosed.
Type:
Application
Filed:
May 10, 2021
Publication date:
November 10, 2022
Applicants:
AT&T Intellectual Property I, L.P., Emory University
Abstract: Provided is a processor configured to compute elements affecting an optimization matrix in connection with a first measurement, among elements of a Hessian matrix, instead of generating a whole Hessian matrix for a map point and a camera pose based on all measurements, and accumulate the computed elements over the optimization matrix used to perform optimization operations in relation to states of the map point and the camera pose.
Type:
Application
Filed:
October 27, 2021
Publication date:
November 10, 2022
Applicants:
SAMSUNG ELECTRONICS CO., LTD., University of Seoul Industry Cooperation Foundation
Inventors:
Myungjae JEON, Kichul KIM, Namseop KWON, Hongseok LEE, San KIM, Wooseok SEONG, Seongmin CHOI
Abstract: Hybrid suspension cultures supplementing soluble extracellular matrix (ECM) for growth of organoids is disclosed. Viable lung organoid from epithelial, endothelial, and fibroblast human stable cell lines in suspension culture are also disclosed.
Abstract: Provided is an effective stereognosis training system that integrates hardware and software to provide a simple, reliable, quantitative system to provide tactile rehabilitation and progress monitoring. The system can include an interactive device including a novel set of objects, that are combined with neuromodulatory systems such as wireless closed-loop vagus nerve stimulation to improve neural plasticity and expedite functional recovery. The system can send updates to therapists or clinicians to monitor progress and encourage compliance with prescribed therapy.
Type:
Application
Filed:
May 30, 2022
Publication date:
November 10, 2022
Applicant:
Board of Regents, The University of Texas System
Abstract: A method of making nanoparticles including a semiconducting nitride is provided. The method includes reacting precursors in a gas phase to form the nanoparticles including the semiconducting nitride. The precursors include at least one of a gallium (Ga) precursor or an indium (In) precursor and a nitrogen (N) precursor. The semiconducting nitride is In1?xGaxN, where 0?x?1. Structures that include the nanoparticles and systems for making the nanoparticles are also provided.
Type:
Application
Filed:
September 28, 2020
Publication date:
November 10, 2022
Applicant:
Board of Trustees of Michigan State University
Inventors:
Richard R. LUNT, III, Rebecca J. ANTHONY, Alexander H. HO, Rajib MANDAL
Abstract: Disclosed herein are methods for delivering a composition comprising an adeno-associated virus (AAV) to one or more pancreatic cells in a subject. Also disclosed are adeno-associated viral vectors for use in these methods.
Abstract: A system for testing biological samples includes a frame having first and second sides and an aperture extending through the frame from the first side to the second side. First and second covers are attached to the first and second sides of the frame to form a well bounded by the frame, the first cover, and the second cover. An electromagnetic imaging device is used to image the biological sample through the first cover. A method is also conceived, wherein a first fluid is supplied to the well, the first fluid including live cells. A biofilm is grown from the live cells. A second fluid is supplied to the well and the biofilm is imaged using the electromagnetic imaging device.
Type:
Application
Filed:
October 29, 2020
Publication date:
November 10, 2022
Applicants:
Colgate-Palmolive Company, Regents of the University of Michigan
Inventors:
Carlo Daep, Deon HINES, Harsh Mahendra TRIVEDI, James MASTERS, LaTonya KILPATRICK-LIVERMAN, Luciana RINAUDI MARRON, Lynette ZAIDEL, Alexander H. RICKARD, Derek S. SAMARIAN, Gregory KRUSE
Abstract: A magnetic soil remediation agent for soil heavy metal pollution and a preparation method and application thereof are provided. The magnetic soil remediation agent is prepared by using remediation agent framework material and magnetic core material as raw materials, and heavy metal collector as modifier; said framework material is silicon dioxide activated by strong alkali; said magnetic core material comprises magnetic materials Fe3O4 and ?-Fe2O3; said modifier comprises ethylenediaminetetraacetic acid (EDTA, nitrilotriacetic acid trisodium salt (NTA, (S,S)-ethylenediamine-N,N-disuccinic acid trisodium salt (EDDS) and mercaptoethylamine. The remediation agent of the present invention can effectively passivate the heavy metals in the soil, reduce their available contents, and inhibit the absorption of heavy metals by plants.
Abstract: Provided herein are methods for preparing a sequencing library that includes nucleic acids from a plurality of single cells. In one embodiment, the sequencing library includes nucleic acids that represent the chromatin accessibility from the plurality of single cells. In one embodiment, the nucleic acids include three index sequences. In another embodiment, the present disclosure provides methods for characterizing rare events in isolated cells and nuclei.
Type:
Application
Filed:
December 18, 2020
Publication date:
November 10, 2022
Applicants:
Illumina, Inc., University of Washington
Inventors:
Jay Shendure, Darren Cusanovich, Riza Daza, Frank Steemers, Andrew Kennedy
Abstract: Provided herein are methods of preparing cell-free DNA (cfDNA) for sequencing such that variant allele frequencies are maintained. Also provided are sequencing libraries prepared according to such methods. In addition, methods are provided for analyzing sequencing reads to determine variant allele frequencies. These methods may be used for diagnosing and/or evaluating cancer patients.
Type:
Application
Filed:
June 25, 2020
Publication date:
November 10, 2022
Applicant:
Board of Regents, The University of Texas System
Inventors:
Rajyalakshmi LUTHRA, Dzifa Y. DUOSE, Scott KOPETZ, Ignacio I. WISTUBA, Stephanie ZALLES, Saradhi MALLAMPATI
Abstract: An apparatus and a method for caring emotion of a driver based on a vehicle sound, may include a detector configured to detect driving information of the vehicle and body information of a user, a non-transitory storage to store instructions, and a processor to execute the instructions. The processor determines an emotional status of the driver by use of at least one of the driving information or the body information, to generate a healing sound by designing a virtual sound based on the driving information and the emotional status of the driver, and to generate and output the healing sound.
Type:
Application
Filed:
October 27, 2021
Publication date:
November 10, 2022
Applicants:
HYUNDAI MOTOR COMPANY, Kia Corporation, Seoul National University R&DB Foundation
Inventors:
Ki Chang KIM, Eun Soo JO, Tae Kun YUN, Sang Jin HONG, Dong Chul PARK, Kyoung Jin CHANG, Ju In KIM, Jin Sung LEE, Myung Hwan YUN, Sung Ho KIM
Abstract: The purpose of the present invention is to produce a chimeric antigen receptor (CAR) specific to glypican-1 (GPC-1) and to treat squamous cell carcinoma with genetically modified cells capable of expressing the CAR. The present invention provides: a chimeric antigen receptor for use in the treatment and/or prevention of squamous cell carcinoma, said chimeric antigen receptor comprising an extracellular domain capable of binding to GPC-1, a transmembrane domain and one or multiple intracellular domains, wherein at least one of the intracellular domains is an intracellular domain containing a primary cytosolic signaling sequence or an intracellular domain containing both a primary cytosolic signaling sequence and a secondary cytosolic signaling sequence; a genetically modified cell capable of expressing the chimeric antigen receptor; and a cell preparation containing the cell.
Type:
Application
Filed:
June 22, 2022
Publication date:
November 10, 2022
Applicants:
Keio University, Iwate Medical University
Abstract: The present invention relates to an indirect three-dimensional co-culture. The indirect co-culture may comprise bone marrow niche cells, tumor cells and a culture medium. The bone marrow niche cells and the tumor cells may be incubated in the culture medium without direct contact between the bone marrow niche cells and the tumor cells. The tumor cells may be dormant or reactivated. Also provided are a method for preparing the indirect co-culture and a method for screening for an agent capable of inhibiting reactivation of dormant tumor cells or promoting dormancy of proliferating tumor cells.
Type:
Application
Filed:
September 30, 2020
Publication date:
November 10, 2022
Applicant:
University of Delaware
Inventors:
April Kloxin, Lina Pradhan, Robert Sikes, Kenneth van Golen, DeVonte Moore
Abstract: A full probability-based seismic risk analysis method for a tunnel under fault dislocation comprises: evaluating a magnitude-frequency relationship of a fault; obtaining a probabilistic seismic risk curve of a fault dislocation; calculating a series of bending moments of a tunnel lining under different fault dislocations; obtaining a series of damage index values RM of the tunnel; obtaining a vulnerability model of the tunnel damaged by fault dislocation; calculating a probabilistic risk that the tunnel crossing the fault is damaged due to the dislocation of the active fault; obtaining a probability P that the damage state is equal to or higher than a certain damage state within a specified period; and using the results to guide the assessment of the seismic risk of the tunnel crossing the fault. Modeling and analysis can be performed according to the actual situation of the tunnel crossing the fault with different factors.
Type:
Application
Filed:
May 5, 2022
Publication date:
November 10, 2022
Applicant:
Southwest Jiaotong University
Inventors:
Ran YUAN, Yin CHENG, Liping WANG, Chaolie NING, Xiaohui YU, Wenwen LUO, Wenqi DU, Shuoyu LIU, Jun DU
Abstract: Disclosed herein is Arrowland, a web-based software tool for inputting, managing and viewing multiomics data, such as transcriptomics, proteomics, metabolomics and fluxomics data in an interactive, intuitive and multiscale system.
Type:
Grant
Filed:
January 22, 2019
Date of Patent:
November 8, 2022
Assignees:
The Regents of the University of California, National Technology & Engineering Solutions of Sandia, LLC
Inventors:
Hector Garcia Martin, Garrett W. Birkel, Ling Liang, William Morrell, Mark Forrer
Abstract: Methods and apparatus are provided for imaging a response of a sample to radiative heating. A method in accordance with one embodiment has steps of: illuminating a first area of the sample with a radiative heating beam; illuminating a portion of the first area with a probe beam; collecting light exiting the sample due to interaction of the probe beam with the sample; superimposing the light exiting the sample with a reference beam derived from the probe beam, wherein the reference is characterized by an optical phase relative to the probe beam; detecting a spatial portion of the light exiting the sample and the reference beam with at least one detector to generate an interference signal; and processing the interference signal to obtain an image of the sample associated with absorption of the radiative heating beam.
Type:
Grant
Filed:
January 3, 2020
Date of Patent:
November 8, 2022
Assignees:
The Board of Trustees of the University of Illinois, Asociación Centro De Investigación Cooperativa
Inventors:
Martin Schnell, Paul Scott Carney, Rohit Bhargava
Abstract: Disclosed is a method for controlling a biofilm, for removing a formed biofilm and/or for controlling a growth of microorganisms, preferably bacteria, in an aqueous environment of an industrial manufacturing process including cellulosic fibre material. In the method, a composition including a compound selected from a group consisting of 3-[(4-methylphenyl)sulphonyl]-2-propenenitrile and 4-amino-N-2-thiazolyl-benzenesulphonamide is administered to the aqueous environment of the process.
Type:
Grant
Filed:
August 28, 2018
Date of Patent:
November 8, 2022
Assignees:
Kemira Oyj, University of Copenhagen
Inventors:
Jaakko Simell, Marko Kolari, Michael Givskov, Tim Tolker-Nielsen, Morten Levin Rybtke, Jens Bo Andersen
Abstract: The disclosed embodiments relate to multimodal imaging system, comprising: a fiber-coupled fluorescence imaging system, which operates based on ultra-violet (UV) excitation light; and a fiber-coupled optical coherence tomography (OCT) imaging system. The multimodal imaging system also includes a fiber optic interface comprising a single optical fiber, which facilitates light delivery to a sample-of-interest and collection of returned optical signals for both the fluorescence imaging system and the OCT imaging system. During operation of the system, the single optical fiber carries both UV light and coherent infrared light through two concentric light-guiding regions, thereby facilitating generation of precisely co-registered optical data from the fluorescence imaging system and the OCT imaging system.
Type:
Grant
Filed:
April 12, 2018
Date of Patent:
November 8, 2022
Assignee:
The Regents of the University of California
Inventors:
Benjamin E. Sherlock, Diego R. Yankelevich, Julien Bec, Laura Marcu
Abstract: The invention pertains to a method for treating a neoplasm, such as colorectal cancer, using hollow silica spheres (“HSS”). It also is directed to a method for making uncalcined HSS, calcined HSS from which phenyl groups have been removed, and HSS incorporating particles of Fe3O4, as well as compositions containing HSS.
Type:
Grant
Filed:
May 3, 2019
Date of Patent:
November 8, 2022
Assignee:
Imam Abdulrahman Bin Faisal University
Inventors:
Ayhan Bozkurt, Seyda Tugba Gunday Anil, Firdos Alam Khan, Sultan Akhtar
Abstract: The disclosure generally relates to compositions and methods for the treatment of cancer. In some aspects, disclosed herein are methods for the induction of synthetic lethality with epigenetic therapy (ISLET) using a combination of at least one epigenetic compound and at least one chemotherapeutic agent. Also disclosed herein are screening methods for identifying compounds that induce killing of cancer cells when combined with at least one epigenetic compound. Further disclosed herein are methods of potentiating a therapeutic effect of a chemotherapeutic agent against a cancer, comprising administering to a subject having the cancer an epigenetic compound in an amount effective to potentiate the therapeutic effect of the chemotherapeutic agent against the cancer.
Type:
Grant
Filed:
June 6, 2018
Date of Patent:
November 8, 2022
Assignee:
The Johns Hopkins University
Inventors:
Srinivasan Yegnasubramanian, William G. Nelson, Ajay Vaghasia, Philipp Nuhn